Sandra Croockewit
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Hematology top 5%
- Multiple Myeloma Research and Treatments
Papers in
- Hematology 22
- Multiple Myeloma Research and Treatments 14
- Hematopoietic Stem Cell Transplantation 7
- Chronic Myeloid Leukemia Treatments 4
- Co-authors
- I. Jolanda M. de VriesCarl G. FigdorCornelis J.A. PuntWim J.G. OyenNicole M. ScharenborgGosse J. AdemaW. Joost LesterhuisGerty Schreibelt
- Journals
- Blood (6 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (3 papers)Transplant International (2 papers)Cancer Immunology Immunotherapy (2 papers)HemaSphere (2 papers)
- Partner nations
- NetherlandsBelgiumUnited States
In The Last Decade
Sandra Croockewit
34 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 80
- Immunology 845
- Hematology 318
- Oncology 651
- Nephrology 155
- Transplantation 58
Countries citing papers authored by Sandra Croockewit
This map shows the geographic impact of Sandra Croockewit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Croockewit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Croockewit more than expected).
Fields of papers citing papers by Sandra Croockewit
This network shows the impact of papers produced by Sandra Croockewit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Croockewit. The network helps show where Sandra Croockewit may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandra Croockewit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2022 | 12 | |
| 3 | 2021 | 22 | |
| 4 | 2019 | 23 | |
| 5 | 2018 | 5 | |
| 6 | 2017 | 10 | |
| 7 | 2016 | 53 | |
| 8 | 2013 | 289 | |
| 9 | 2013 | 1 | |
| 10 | 2012 | 20 | |
| 11 | 2011 | 138 | |
| 12 | 2011 | 55 | |
| 13 | 2010 | 59 | |
| 14 | 2009 | 89 | |
| 15 | Intensive versus double intensive therapy in untreated multiple myeloma | 2005 | 6 |
| 16 | 2004 | 46 | |
| 17 | 2004 | 45 | |
| 18 | 2000 | 2 | |
| 19 | 1999 | 7 | |
| 20 | 1999 | 1 |
About Sandra Croockewit
Sandra Croockewit is a scholar working on Hematology, Transplantation, Genetics, Nephrology and Oncology, having authored 34 papers that have together received 1.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (14 papers), Immunotherapy and Immune Responses (7 papers), Hematopoietic Stem Cell Transplantation (7 papers), Protein Degradation and Inhibitors (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), vaccines and immunoinformatics approaches (4 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Immunology (845 citations), Hematology (318 citations), Oncology (651 citations), Nephrology (155 citations) and Transplantation (58 citations). Sandra Croockewit has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include I. Jolanda M. de Vries, Carl G. Figdor, Cornelis J.A. Punt, Wim J.G. Oyen, Nicole M. Scharenborg, Gosse J. Adema, W. Joost Lesterhuis, Gerty Schreibelt, Jack F.M. Wetzels and Margrét B. Andrésdóttir. Their work appears in journals such as Blood, Clinical Chemistry and Laboratory Medicine (CCLM), Transplant International, Cancer Immunology Immunotherapy and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.